Buy or sell Datavant stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Datavant Stock
Healthcare Data Solutions
About Datavant Stock
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and sharing health data. The platform that the company offers organizes healthcare data for use in clinical trial decision-making. Its focus is on the employment of artificial intelligence to improve the clinical trial process and to improve the design and interpretation of clinical trials, helping pharmaceutical companies to manage the privacy, security, compliance, and trust required to enable safe data sharing. Travis May established Datavant in San Francisco, California in 2017.
Investors
Cigna Ventures
Founders Fund
Lyft, SpaceX, Spotify, Airbnb, Stripe, Anduril Industries, Flexport, Palantir Technologies, Wish, Compass
Johnson & Johnson Innovation – JJDC
Octave Group
Funding History
| April 2018 | $40.5M |
|---|---|
| October 2020 | $40.0M |
Management
Chief Executive Officer
Travis May
Chief Financial Officer
Mike Burwell
Press
vator - Aug, 22 2022
prnewswire - Apr, 20 2022
globenewswire - Mar, 16 2022
fiercebiotech - Aug, 24 2021
aithority - Jul, 29 2021
fiercebiotech - Jun, 9 2021
genomeweb - Mar, 4 2021
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
